Management of Lung Nodules Detected by Volume CT Scanning

Participants who were at an increased risk for lung cancer were enrolled in a trial to determine whether CT screening reduces mortality from lung cancer. In this study, volume measurements and volume doubling times were used to evaluate the noncalcified lung nodules that were detected by CT scanning...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 361; no. 23; pp. 2221 - 2229
Main Authors van Klaveren, Rob J, Oudkerk, Matthijs, Prokop, Mathias, Scholten, Ernst T, Nackaerts, Kristiaan, Vernhout, Rene, van Iersel, Carola A, van den Bergh, Karien A.M, van 't Westeinde, Susan, van der Aalst, Carlijn, Thunnissen, Erik, Xu, Dong Ming, Wang, Ying, Zhao, Yingru, Gietema, Hester A, de Hoop, Bart-Jan, Groen, Harry J.M, de Bock, Geertruida H, van Ooijen, Peter, Weenink, Carla, Verschakelen, Johny, Lammers, Jan-Willem J, Timens, Wim, Willebrand, Dik, Vink, Aryan, Mali, Willem, de Koning, Harry J
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 03.12.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Participants who were at an increased risk for lung cancer were enrolled in a trial to determine whether CT screening reduces mortality from lung cancer. In this study, volume measurements and volume doubling times were used to evaluate the noncalcified lung nodules that were detected by CT scanning at baseline and at years 1, 2, and 4 of the trial. With the use of these volumetric methods, the authors found that the chances of finding lung cancer by CT scanning 1 and 2 years after a negative baseline test were 1 in 1000 and 3 in 1000, respectively. With the use of volumetric methods, the authors found that the chances of finding lung cancer by CT scanning 1 and 2 years after a negative baseline test were 1 in 1000 and 3 in 1000, respectively. The use of multidetector computed tomography (CT) has increased the chance of finding noncalcified pulmonary nodules, 1 , 2 and as a result, clinicians often face the problem of deciding on the best course of action with respect to such nodules when they are found in asymptomatic subjects who have an increased risk for lung cancer. 3 This difficulty is especially evident in CT-based screening programs for lung cancer. The current practice is to refer participants in these programs for additional diagnostic evaluation if they have a noncalcified nodule that is larger than 5 mm in diameter. 4 – 9 In designing the Dutch–Belgian randomized . . .
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa0906085